Belimumab (Anti-TNFSF13B / BAFF / CD257)

Ask supplier a question | View on supplier's website

Belimumab (Anti-TNFSF13B / BAFF / CD257) is a human IgG1λ monoclonal antibody that inhibits B-cell activating factor (BAFF). Belimumab can be used for systemic lupus erythematosus (SLE) research. MW : 144.56 kDa.

Supplier	Selleck Chemicals
Product #	A2316
Sku #	A2316-1mg*5
Pricing	1mg*5, $490.00

Feedback